The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 18, 2018
Filed:
Jul. 29, 2016
Chia Tai Tianqing Pharmaceutical Group Co., Ltd., Lianyungang, Jiangsu Province, CN;
Lianyungang Runzhong Pharmaceutical Co., Ltd., Lianyungang, Jiangsu Province, CN;
Centaurus Biopharma Co., Ltd., Beijing, CN;
Shulong Wang, Beijing, CN;
Na Zhao, Beijing, CN;
Xijie Liu, Beijing, CN;
Yuandong Hu, Beijing, CN;
Hui Zhang, Beijing, CN;
Hong Luo, Beijing, CN;
Yong Peng, Beijing, CN;
Dengming Xiao, Beijing, CN;
Yongxin Han, Beijing, CN;
Xiquan Zhang, Lianyungang, CN;
Xin Tian, Lianyungang, CN;
Chia Tai Tianqing Pharmaceutical Group Co., Ltd., Lianyungang, Jiangsum, CN;
Lianyungang Runzhong Pharmaceutical Co., Ltd., Lianyungang, Jiangsu, CN;
Centaurus Biopharma Co., Ltd., Beijing, CN;
Abstract
The present application relates to compounds represented by general formula (I), general formula (II) or general formula (III), and pharmaceutically acceptable salts or hydrates thereof, preparation methods thereof, and pharmaceutical compositions thereof. The compounds represented by general formula (I), general formula (II) or general formula (III) have inhibitory activities against isocitrate dehydrogenase 2 (IDH2), thereby being capable of treating IDH2 mutation-induced cancers.